CompaniesByCap
COLL
Collegium Pharmaceutical Inc. (COLL)
NASDAQ · Healthcare

Collegium Pharmaceutical Inc. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenues
Revenue780.6M631.4M566.8M463.9M276.9M310.0M296.7M280.4M28.5M1.7M
Gross Profit463.3M377.3M326.2M209.5M150.6M179.8M103.0M114.7M25.9M1.5M
Profitability
Operating Income179.6M169.9M167.0M33.3M17.6M56.2M-23.7M-20.7M-75.4M-94.1M
EBITDA-23.0M-19.6M-74.9M-93.4M
Net Income62.9M69.2M48.2M-25.0M71.5M26.8M-22.7M-39.1M-74.9M-94.2M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)40M40M42M34M41M35M33M33M33M29M

Collegium Pharmaceutical Inc. Income Statement — FAQ

Collegium Pharmaceutical Inc. (COLL) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see COLL's income statement history?

The chart and table above show Collegium Pharmaceutical Inc.'s income statement by year and by quarter, including the growth rate.